BERKELEY, CA (UroToday.com) - Many treatment options exist for non-metastatic prostate cancer patients. Androgen deprivation therapy (ADT), which suppresses the production of testicular androgens by medical or surgical castration, is used in this setting as primary ADT (i.e., monotherapy) or in combination with external beam radiotherapy (EBRT).